经动脉栓塞治疗2型内漏的单中心结果
该单中心回顾性研究分析了2003至2017年间36例EVAR后需再干预的2型内漏患者,其中28例接受经动脉栓塞。该技术成功率为71.4%,临床成功率为62.5%,再干预率35.7%,动脉瘤破裂率10.7%,开放手术转换率7.1%,动脉瘤相关死亡率14.3%。结论认为T2E治疗后不良结局风险较高,仍需严格影像随访。
要点
- 经动脉栓塞治疗T2E技术成功率71.4%,临床成功率62.5%。
- T2E治疗后再干预率35.7%,动脉瘤相关死亡率14.3%。
- T2E治疗后需严格影像随访以监测不良结局。
核心结论
- T2E治疗后相当比例患者面临不良结局风险,需严格影像随访。
研究设计与样本
- 单中心前瞻性维护数据库的回顾性分析,纳入2003至2017年连续治疗的T2E患者。
- 共528例择期EVAR,36例(6.8%)发生需再干预的T2E,其中28例接受经动脉栓塞。
主要发现
- 经动脉栓塞技术成功率为71.4%,临床成功率为62.5%。
- 35.7%的患者需要再次干预。
- 随访期间动脉瘤破裂率为10.7%(n=3/28),开放手术转换率为7.1%(2/28),动脉瘤相关死亡率为14.3%(n=4/28)。
关键数值与推荐
- 技术成功定义为治疗后最终血管造影控制中无内漏。
- 临床成功定义为治疗后一年对比增强CT显示瘤囊增长不超过5 mm。
临床怎么用
- 对EVAR后T2E患者行经动脉栓塞后应坚持严格影像随访以早期发现不良结局。
局限性
- 单中心回顾性分析,样本量较小(经动脉栓塞28例),可能限制结论外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 endoleaks (T2Es) are the main cause of reintervention after endovascular repair of abdominal aortic aneurysms (EVAR). The objective of this study is to quantify success rates of T2E treatment. METHODS: This study involves a retrospective analysis of a prospectively maintained database containing data on all consecutive patients treated for a T2E between 2003 and 2017 in a single center. Technical success was defined as absence of endoleak in the final angiographic control after treatment. Clinical success was defined as absence of sac growth over 5 mm in the contrast-enhanced computed tomography performed a year thereafter. Statistics included Kaplan-Meier survival estimates. RESULTS: A total of 528 elective EVARs were performed in the period. Thirty-six of these (6.8%) developed a T2E requiring reintervention, a median of 37.9 months after EVAR. Twenty-five percent of the treatments were performed more than 5 years after intervention. Twenty-eight of the 36 treatments were performed via transarterial embolization. For this technique, technical success was 71.4% and clinical success was 62.5%. A subsequent reintervention was required in 35.7% of patients. In this cohort, the rate of aneurysm rupture was 10.7% (n = 3/28), open surgical conversion was needed in 2 of 28 cases (7.1%), and rate of aneurysm-related death was 14.3% (n = 4/28) over follow-up. CONCLUSIONS: A high percentage of patients are at risk of adverse outcomes after T2E treatment. Strict imaging follow-up is still needed in this population.
引用
- Arenas Azofra E, Rey VM, Marcos FÁ, et al. Results of Transarterial Embolization for Treating Type 2 Endoleaks: A Single-Center Experience. Ann Vasc Surg. 2019. PMID: 31381998. doi:10.1016/j.avsg.2019.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。